Review of bilayer tablet technology
- PMID: 24370841
- DOI: 10.1016/j.ijpharm.2013.12.028
Review of bilayer tablet technology
Abstract
Therapeutic strategies based on oral delivery of bilayer (and multilayer) tablets are gaining more acceptance among brand and generic products due to a confluence of factors including advanced delivery strategies, patient compliance and combination therapy. Successful manufacturing of these ever more complex systems needs to overcome a series of challenges from formulation design to tablet press monitoring and control. This article provides an overview of the state-of-the-art of bilayer tablet technology, highlighting the main benefits of this type of oral dosage forms while providing a description of current challenges and advances toward improving manufacturing practices and product quality. Several aspects relevant to bilayer tablet manufacturing are addressed including material properties, lubrication, layer ordering, layer thickness, layer weight control, as well as first and final compression forces. A section is also devoted to bilayer tablet characterization that present additional complexities associated with interfaces between layers. The available features of the manufacturing equipment for bilayer tablet production are also described indicating the different strategies for sensing and controls offered by bilayer tablet press manufacturers. Finally, a roadmap for bilayer tablet manufacturing is advanced as a guideline to formulation design and selection of process parameters and equipment.
Keywords: Bilayer tablet manufacturing; Delamination; Interfacial strength; Layered tablets; Tablet compression.
Copyright © 2013 Elsevier B.V. All rights reserved.
Similar articles
-
Interfacial bonding in formulated bilayer tablets.Eur J Pharm Biopharm. 2020 Feb;147:69-75. doi: 10.1016/j.ejpb.2019.12.009. Epub 2019 Dec 21. Eur J Pharm Biopharm. 2020. PMID: 31870828
-
Axial strength test for round flat faced versus capsule shaped bilayer tablets.Pharm Dev Technol. 2015 Mar;20(2):139-45. doi: 10.3109/10837450.2013.852570. Epub 2013 Nov 13. Pharm Dev Technol. 2015. PMID: 24219774
-
Critical factors in manufacturing multi-layer tablets--assessing material attributes, in-process controls, manufacturing process and product performance.Int J Pharm. 2010 Oct 15;398(1-2):9-13. doi: 10.1016/j.ijpharm.2010.07.025. Epub 2010 Jul 23. Int J Pharm. 2010. PMID: 20656000 Review.
-
Development of a new test for the easy characterization of the adhesion at the interface of bilayer tablets: proof-of-concept study by experimental design.Int J Pharm. 2014 Dec 30;477(1-2):476-84. doi: 10.1016/j.ijpharm.2014.10.051. Epub 2014 Nov 1. Int J Pharm. 2014. PMID: 25445527
-
Implementation of Quality by Design (QbD) for development of bilayer tablets.Eur J Pharm Sci. 2023 May 1;184:106412. doi: 10.1016/j.ejps.2023.106412. Epub 2023 Feb 22. Eur J Pharm Sci. 2023. PMID: 36828037 Review.
Cited by
-
Fixed-Dose Combination Formulations in Solid Oral Drug Therapy: Advantages, Limitations, and Design Features.Pharmaceutics. 2024 Jan 26;16(2):178. doi: 10.3390/pharmaceutics16020178. Pharmaceutics. 2024. PMID: 38399239 Free PMC article. Review.
-
Evaluation of the Ejection Pressure for Tracking Internal Cracks during Compaction in Bilayer Tablet Formulations Using Experimental and Finite Element Methods.Pharmaceuticals (Basel). 2024 Mar 2;17(3):330. doi: 10.3390/ph17030330. Pharmaceuticals (Basel). 2024. PMID: 38543116 Free PMC article.
-
Structure based release kinetics analysis of doxazosin mesylate sustained-release tablets using micro-computed tomography.Asian J Pharm Sci. 2024 Dec;19(6):100966. doi: 10.1016/j.ajps.2024.100966. Epub 2024 Sep 21. Asian J Pharm Sci. 2024. PMID: 39640054 Free PMC article.
-
Development and Evaluation of Bilayer Sustained-Release Tablets of Ruxolitinib Using Discriminative Pharmacokinetic Analysis and IVIVC.Pharmaceutics. 2025 Mar 28;17(4):432. doi: 10.3390/pharmaceutics17040432. Pharmaceutics. 2025. PMID: 40284427 Free PMC article.
-
Tailoring of Rosuvastatin Calcium and Atenolol Bilayer Tablets for the Management of Hyperlipidemia Associated with Hypertension: A Preclinical Study.Pharmaceutics. 2022 Aug 4;14(8):1629. doi: 10.3390/pharmaceutics14081629. Pharmaceutics. 2022. PMID: 36015255 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources